|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,242.10 INR | +1.27% |
|
-3.03% | +2.06% |
| 10/12 | Mankind Pharma receives tax penalty of 153.2 million rupees | RE |
| 01/12 | EQT Shows Interest in Vitabiotics - ET | FW |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 45.42x | 5.54x | -49.34x | 6.67x | 26.71x | 34.56x | 0.21% | 1.01TCr | ||
| 47.06x | 35.93x | 0.49x | 15.58x | 34.57x | 37.24x | 0.55% | 96TCr | ||
| 20.75x | 6.57x | 0.27x | 5.76x | 16.04x | 17.54x | 2.42% | 51TCr | ||
| 74.8x | 698.91x | 3.19x | 7.32x | 17.57x | 18x | 2.96% | 39TCr | ||
| 19.82x | 7.06x | 0.3x | 4.95x | 12.32x | 13.86x | 2.9% | 36TCr | ||
| 28.42x | 6.39x | 0.6x | 5.34x | 15.85x | 16.69x | 1.72% | 29TCr | ||
| 19.88x | 6.13x | 0.97x | 5.26x | 12.34x | 13.39x | 2.88% | 27TCr | ||
| 13.91x | 4.98x | 0.9x | 4.55x | 9.79x | 11.01x | 2.99% | 27TCr | ||
| 16.61x | 9.03x | 8.33x | 5.87x | 12.14x | 14.07x | 3.04% | 27TCr | ||
| 25.37x | 19.3x | 0.37x | 6.03x | 10.33x | 13.85x | 2.95% | 17TCr | ||
| 18.14x | 6.7x | 0.01x | 5.61x | 10.25x | 12.32x | 2.73% | 15TCr | ||
| 12.39x | 1.58x | 0.28x | 3.01x | 7.55x | 8.78x | 6.8% | 14TCr | ||
| 11.97x | 1.26x | 0.26x | 2.54x | 8.27x | 9.12x | 5.11% | 11TCr | ||
| 29.31x | 6.08x | -0.03x | 8.81x | 19.05x | 19.77x | -.--% | 12TCr | ||
| 13.63x | 5.62x | -0.07x | 3.06x | 9.05x | 9.43x | 4.41% | 11TCr | ||
| 13.41x | 5.2x | 0.11x | 2.72x | 7.96x | 9.06x | 3.5% | 10TCr | ||
| 32.41x | 7.03x | 3.06x | 10.44x | 20.42x | 21.88x | 3.01% | 8.72TCr | ||
| 48.35x | 7.11x | 1.45x | 11.79x | 38.78x | 40.79x | 0.43% | 6.15TCr | ||
| 41.51x | 1.15x | 0.54x | 2.62x | 9.73x | 27.59x | 3.98% | 4.98TCr | ||
| Average | 28.06x | 44.29x | -1.49x | 6.21x | 15.72x | 18.37x | 2.77% | 23.43TCr | |
| Weighted average by Cap. | 31.28x | 73.76x | 1.09x | 7.75x | 18.22x | 20.04x | 2.4% |
- Stock Market
- Equities
- MANKIND Stock
- Sector Mankind Pharma Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















